- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07369479
Effects of a Health Literacy-tailored Self-management Intervention on People With Hypertension
Effects of a Health Literacy-tailored Self-management Intervention on Blood Pressure Levels Among People With Hypertension: A Randomised Controlled Trial
This project aims to investigate the effects of a health literacy-tailored self-management intervention among people with hypertension and low health literacy. The primary research question examines the impact of this intervention on blood pressure levels in this population.
Participants will take part in a 6-week intervention consisting of three onsite sessions and three telephone-based sessions, with one session delivered per week. Health literacy-tailored educational materials will be developed to support participants throughout the intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nhi Thi Vo, PhD post-candidacy
- Phone Number: (+852) 56257068
- Email: vtnhi@link.cuhk.edu.hk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18 years or older
- Diagnosed with primary hypertension, blood pressure ≥ 140/90 mmHg and taking at least one anti-hypertensive drug
- Health literacy score of 33 or below
- Access to a smartphone
- Able to read and speak in Vietnamese language.
Exclusion Criteria:
- Pregnant women
- Patients with secondary hypertension, psychiatric disorders or cognitive impairments.
- Unable to answer telephone calls.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
|
The participants in the intervention group will receive usual care combine with three weekly face-to-face group sessions (1 hour/week, 6-8 participants) at community health centres, followed by three weekly individual phone call sessions (20 minutes/session).
|
|
No Intervention: Control group
The participants in the control group will receive care as usual.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure levels
Time Frame: Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
Participants' blood pressure levels will be measured using a validated digital sphygmomanometer.
|
Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of participants achieving optimal blood pressure control
Time Frame: Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
the number of participants with optimal blood pressure control at each measurement time point divided by the total number of patients enrolled in the group
|
Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
|
Medication adherence
Time Frame: Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
The Vietnamese General Medication Adherence Scale (GMAS) will be used to measure medication adherence across 11 items covering forgetfulness, intentional skipping, complex regimens, and cost-related non-adherence.
Items are rated on a 4-point Likert scale from 0 (Strongly disagree) to 3 (Strongly agree), with total scores 0-33; higher scores indicate better adherence.
In addition, pill count (the number of pills not used compared to the number of pills received at the most recent prescription filling) will be used as an objective measurement to confirm medication adherence among participants.
|
Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
|
Self-management behaviours
Time Frame: Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
The Vietnamese version of the Hypertension Self-Care Profile Behaviour Scale (HT-SCPB) will be used to measure self-management behaviour.
It includes 20 items that address different aspects of self-management behaviour: checking BP, regular visits to doctors, medication adherence, and lifestyle modifications.
Each item will be rated on a 4-point Likert scale from 1 (never/rarely) to 4 (always).
The total score 20-80, with a higher score indicating higher hypertension self-management behaviours.
|
Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
|
Self-efficacy
Time Frame: Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
The Vietnamese version of the Self-Efficacy for Managing Chronic Diseases (SEM-CD) scale will assess self-efficacy across six items, including confidence in managing fatigue, pain, emotional distress, other symptoms, health-related tasks, and actions beyond medication.
Items are rated on a 10-point Likert scale from 1 (not at all confident) to 10 (totally confident), with the mean score (1-10) representing overall self-efficacy.
|
Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
|
Health literacy
Time Frame: Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
The 12-item Vietnamese Short-Form of Health Literacy Questionnaire (HLS-SF12) will be used to measure HL levels (Duong et al., 2019).
It includes twelve items that assess how easy it is for patients to find (4 items), understand (3 items), appraise (3 items) and apply health information (2 items).
Each item will be rated on a 4-Likert scale (from 1= "Very difficult" to 4="Very easy").
The total score of the scale will be calculated by the formula HL Index = (Mean-1) x (50/3), where Mean is the average score of the 12 items.
The HL Index ranges from 0 to 50; a higher score indicates better HL.
|
Baseline, T1 (immediately post-intervention) and T2 (3 months post-intervention)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2025.809
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension (HTN)
-
Sarfez Pharmaceuticals, Inc.Recruiting
-
University Hospital, GrenobleRecruiting
-
Arnatar Therapeutics, Inc.Completed
-
Cairo UniversityNot yet recruiting
-
Foundation University IslamabadRecruiting
-
Arnatar Therapeutics, Inc.Active, not recruiting
-
Qilu Pharmaceutical Co., Ltd.Enrolling by invitation
-
Novartis PharmaceuticalsRecruitingHypertension (HTN)United States, Singapore
-
Aktiia SAMassachusetts General Hospital; Brigham and Women's HospitalRecruitingHypertension (HTN)United States
Clinical Trials on health literacy-tailored self-management intervention
-
Griffin HospitalConnecticut Health FoundationCompleted
-
Nova Southeastern UniversityNational Institute of Mental Health (NIMH)CompletedHuman Immunodeficiency Virus I InfectionUnited States
-
Bartın UnıversityNot yet recruitingHypertension | High Blood Pressure
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)CompletedHypertensionUnited States
-
Lovisenberg Diakonale HospitalUniversity of OsloRecruiting
-
University of TromsoCompletedPeriodontal Diseases | Streptococcal Infections | Dental Plaque | Sialorrhea | Dental Calculus | Lactobacillus InfectionNorway
-
University of Southern DenmarkDK-Sønderborg MunicipalityCompleted
-
University Paul Sabatier of ToulouseAssistance Publique Hopitaux De Marseille; Institut National de la Santé Et... and other collaboratorsActive, not recruitingColorectal Cancer ScreeningFrance
-
Oslo University HospitalHelse Sor-Ost (Helse Sør-Øst)Active, not recruitingTransplant Recipient (Kidney)Norway
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); American Society of Health-System...CompletedAcute Coronary Syndrome (ACS)United States